By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Veloxis Pharmaceuticals A/S 

Kogle Allé 4

  DK-2970  Hørsholm  Denmark
Phone: 457-033-3300 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Veloxis Pharmaceuticals A/S (VELO) Announces U.S. FDA Approval of Envarsus XR For Treatment Of Kidney Transplant Patients 7/13/2015 6:35:57 AM
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus XR Demonstrates Differentiated Pharmacokinetic Profile Compared To Twice-Daily Prograf Or Once-Daily Astagraf XL In Stable Kidney Transplant Patients 6/24/2015 10:22:38 AM
U.S. District Court Rules In Veloxis Pharmaceuticals A/S (VELO) Litigation 6/15/2015 6:39:46 AM
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Three Months Of 2015 5/21/2015 6:52:52 AM
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus XR Demonstrates Improved Pharmacokinetic Profile In African-American Transplant Recipients 5/4/2015 6:40:00 AM
Veloxis Pharmaceuticals A/S (VELO) Chooses TrialMaster EDC For Risk-Based Monitoring 3/12/2015 11:02:04 AM
Veloxis Pharmaceuticals A/S (VELO) Publishes Annual Report 2014 3/3/2015 2:14:10 PM
U.S. District Court Sets Briefing Schedule In Veloxis Pharmaceuticals A/S (VELO) Litigation 1/15/2015 8:16:02 AM
Veloxis Pharmaceuticals A/S (VELO) Confirms Receipt Of U.S. FDA Administration Decision 1/13/2015 7:26:26 AM
Veloxis Pharmaceuticals A/S (VELO) Comments On U.S. District Court Order 12/19/2014 9:44:55 AM
123456789
//-->